Combined Determination of Serum CA 19-9 and Tissue Polypeptide Antigen: Why No Improvement in Pancreatic Cancer Diagnosis

Daniela Basso,C Fabris,G. Del Favero,A. Panucci,Mario Plebani,Angonese C,Gioacchino Leandro,Giuseppe Dodi,Angelo Burlina,R. Naccarato

Combined Determination of Serum CA 19-9 and Tissue Polypeptide Antigen: Why No Improvement in Pancreatic Cancer Diagnosis

1988

Daniela Basso
C Fabris
G. Del Favero
A. Panucci
Mario Plebani
Angonese C
Gioacchino Leandro
Giuseppe Dodi
Angelo Burlina
R. Naccarato

CA 19-9 and tissue polypeptide antigen (TPA) were determined in the sera of 28 control subjects, 29 patients with pancreatic cancer, 26 with chronic pancreatitis and 62 with benign and malignant extra

Keywords:

Pathology
Tissue Polypeptide Antigen
Receiver operating characteristic
Pancreatitis
Pancreatic cancer
CA19-9
Medicine
Diabetes mellitus
control subjects

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations